Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ATGENOMIX logo — Data and AI-driven Precision Medicine

ATGENOMIX

Data and AI-driven Precision Medicine

Founded 2017 Taiwan Taiwan 7 employees Series A Biotechnology, Health Care +2

General Information

Company Name ATGENOMIX
Founded Year 2017
Location Taiwan Taiwan
Employees 7
Industries Biotechnology, Health Care, Information Technology +1
Funding Stage Series A
Business Model Platform, SaaS, B2B
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with ATGENOMIX. To contact ATGENOMIX, visit atgenomix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ATGENOMIX compare?

A PDF of ATGENOMIX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ATGENOMIX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ATGENOMIX

ATGENOMIX, founded in 2017, is a pioneering company in the converging fields of biotechnology, health care, and information technology. Based in Taiwan, the company operates with the slogan, "Data and AI-driven Precision Medicine."

Their standout product is a cloud-based biomedical informatics platform designed to unify and operationalize biomedical data leveraging both data analytics and machine learning. This platform is particularly noteworthy for adhering to GA4GH standards, enabling advanced workflows in clinical laboratories.

ATGENOMIX is supported by strategic partnerships with tech giants, being a Microsoft Azure cloud partner in gold data and cloud platform competencies and a Google Health trusted partner in genomics research. Their last significant investment, a Series A round on 01 February 2020, drew backing from notable investors like TransLink Capital, Darwin Venture Management, and Bill Chang. This financial backing emphasizes strong investor confidence in ATGENOMIX's mission to transform healthcare through precision medicine.

Business keywords: Precision Medicine, Biomedical Data Integration, Clinical Genomics, Genomics Research, Data-driven Healthcare, Artificial Intelligence in Healthcare, Machine Learning in Genomics, Bioinformatics, Cloud-based Informatics Platform, GA4GH Standard Workflows, Multimodal Data Analytics, Regulatory Compliance Management, High Performance Computing, Next Generation Sequencing, Microsoft Azure Gold Partner

Services & Products

Cloud-native biomedical informatics platform
SeqsLab Data Hub
SeqsLab Genomics & Health Data Service
Tool registry and version control
Data repository management
Ecosystem integration service
Workflow execution and automation
Machine learning services

Target Customers

Biotech R&D laboratories Clinical laboratories Healthcare and Life Sciences researchers Medtech R&D teams

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 2
TransLink Capital Darwin Venture Management
TransLink Capital, Darwin Venture Management
01 Feb 2020
Seed Undisclosed 1
Darwin Venture Management
Darwin Venture Management
01 Mar 2017

ATGENOMIX Alternatives & Competitors

View All Alternatives
ATGENOMIX vs
Pierian
Pierian United States

Genomics in Practice

Venture round
55 employees
Biotechnology, Health Care
ATGENOMIX vs
hc1
hc1 United States

Healthcare Progress Starts Here®

Venture round
312 employees
Biotechnology, Computing
ATGENOMIX vs
Helix
Helix United States

Helix is the leading population genomics and precision health organization.

Series C
596 employees
Big Data, Biotechnology
View all alternatives

FAQ About ATGENOMIX

Data and AI-driven Precision Medicine
ATGENOMIX was founded in 2017.
ATGENOMIX is headquartered in Taiwan.
ATGENOMIX operates in Biotechnology, Health Care, Information Technology and Internet. Its work centres on Precision Medicine, Biomedical Data Integration, Clinical Genomics and Genomics Research. Its customers include Biotech R&D laboratories, Clinical laboratories and Healthcare and Life Sciences researchers.
ATGENOMIX has a Platform, SaaS and B2B business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
ATGENOMIX has approximately 7 employees.
ATGENOMIX has completed 2 funding rounds. The latest funding stage is Series A.
ATGENOMIX offers: Cloud-native biomedical informatics platform, SeqsLab Data Hub, SeqsLab Genomics & Health Data Service, Tool registry and version control, Data repository management, Ecosystem integration service, Workflow execution and automation, Machine learning services.
Top alternatives and competitors to ATGENOMIX include Pierian, hc1, Helix, Human Longevity, Inc., Congenica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ATGENOMIX and Pierian are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ATGENOMIX, https://bouncewatch.com/company/atgenomix, updated 10 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes